Is Archit Organosys overvalued or undervalued?

As of 15 October 2025, the valuation grade for Archit Organosys has moved from attractive to fair. The company is currently fairly valued, with a PE ratio of 152.53, an EV to EBITDA of 18.67, and a PEG ratio of 0.02. In comparison to peers, Solar Industries is considered very expensive with a PE of 100.5 and an EV to EBITDA of 61.84, while Godrej Industries is attractive with a PE of 35.72 and an EV to EBITDA of 28.85.
Despite a recent stock performance that lags behind the Sensex, with a year-to-date return of -2.93% compared to the Sensex's 5.72%, Archit Organosys maintains a fair valuation status. The company's financial metrics suggest it is not undervalued, especially when contrasted with its peers in the commodity chemicals industry.